We combine the best in innovative materials science with advanced processing technologies. InnoCore’s SynBiosys® injectable bioresorbable solid implants deliver a best-in-class, patient-friendly, and commercially scalable solution for long-acting drug delivery. We are helping our partners bring differentiated, high-value products to market efficiently.
Utilizing low Tg SynBiosys® polymers for extrusion at 60 – 80 °C
Full control over release profile by controlling the diffusion and degradation of the polymer
Sustained controlled release up to 18 months
Fully bioresorbable
Strong IP protection
Our SynBiosys® based injectable bioresorbable solid implants provide an advanced and highly effective solution for sustained drug delivery in the treatment of a wide range of chronic diseases.
Designed for both local and systemic administration, these implants can deliver small molecules, peptides, and proteins in a controlled manner for up to 18 months from a single injection, significantly reducing dosing frequency and improving patient compliance and treatment options.
At the heart of this capability lies InnoCore’s expertise in advanced (micro)extrusion technologies. These processes enable the precise formulation of customer APIs with SynBiosys® bioresorbable polymers. The results are mini-rod implants with consistent quality, tailored release profiles, and optimal therapeutic performance.
Our extrusion systems are designed to operate at relatively low temperatures, which is a crucial factor in preserving the stability and integrity of different API classes. By preventing degradation during manufacturing, InnoCore ensures that therapeutic potency is maintained throughout the product’s shelf life and during in vivo release.
The ability to extrude implants at low temperatures also opens the door to formulating a wide range of active pharmaceutical ingredients, from small molecules to the most delicate biologics that are especially sensitive to heat. This flexibility of working across multiple molecule-type lends a valuable addition to InnoCore’s drug delivery portfolio, complementing other sustained release platforms and offering unique advantages for both new and existing drug products.
Injecting solid implants made from the SynBiosys® bioresorbable polymer presents significant opportunities for optimizing product performance and extending the lifecycle of generic drugs through reformulation into long-acting dosage forms. Such products can differentiate themselves in competitive markets by improving patient adherence, reducing healthcare burden, and delivering consistent therapeutic levels over extended periods.
The versatile SynBiosys® polymers used in these implants allows us to customize the degradation rates, mechanical properties, and drug release patterns to match specific clinical requirements.
InnoCore’s bioresorbable solid implant technology combines precision engineering with versatile polymer science to create best-in-class, long-acting drug delivery solutions. These implants offer our partners a powerful tool to enhance therapeutic performance and market differentiation.
Together, we can transform treatment outcomes and patient experiences.
"*" indicates required fields